Eisai Co Financials
| ESALF Stock | USD 28.86 0.00 0.00% |
Eisai |
Understanding current and past Eisai Co Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Eisai Co's financial statements are interrelated, with each one affecting the others. For example, an increase in Eisai Co's assets may result in an increase in income on the income statement.
Eisai Co Stock Summary
Eisai Co competes with Leef Brands, and Eisai. It offers Aricept for the treatment of alzheimers diseasedementia with Lewy bodies Methycobal for the treatment of peripheral neuropathy and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan. Eisai operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 11322 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 4-6-10, Koishikawa, Tokyo, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.eisai.co.jp |
| Phone | 81 3 3817 3700 |
| Currency | USD - US Dollar |
Eisai Co Key Financial Ratios
There are many critical financial ratios that Eisai Co's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Eisai Co reports annually and quarterly.| Return On Equity | 0.035 | |||
| Return On Asset | 0.0031 | |||
| Target Price | 79.97 | |||
| Beta | 0.17 | |||
| Last Dividend Paid | 160.0 |
Eisai Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Eisai Co's current stock value. Our valuation model uses many indicators to compare Eisai Co value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eisai Co competition to find correlations between indicators driving Eisai Co's intrinsic value. More Info.Eisai Co is rated # 2 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers reporting about 0.09 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Eisai Co is roughly 11.29 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eisai Co's earnings, one of the primary drivers of an investment's value.Eisai Co Systematic Risk
Eisai Co's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Eisai Co volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Eisai Co correlated with the market. If Beta is less than 0 Eisai Co generally moves in the opposite direction as compared to the market. If Eisai Co Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Eisai Co is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Eisai Co is generally in the same direction as the market. If Beta > 1 Eisai Co moves generally in the same direction as, but more than the movement of the benchmark.
Eisai Co March 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Eisai Co help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Eisai Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Eisai Co based on widely used predictive technical indicators. In general, we focus on analyzing Eisai Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Eisai Co's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.87 | |||
| Information Ratio | 0.0198 | |||
| Maximum Drawdown | 27.92 | |||
| Value At Risk | (6.45) | |||
| Potential Upside | 7.1 |
Complementary Tools for Eisai Pink Sheet analysis
When running Eisai Co's price analysis, check to measure Eisai Co's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eisai Co is operating at the current time. Most of Eisai Co's value examination focuses on studying past and present price action to predict the probability of Eisai Co's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eisai Co's price. Additionally, you may evaluate how the addition of Eisai Co to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |